Laboratory Change To Netincome vs Capital Expenditures Analysis

LH Stock

USD 241.16 0.99 0.41%

Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Change To Netincome and its Capital Expenditures accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Change To Netincome vs Capital Expenditures

Change To Netincome vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Change To Netincome account and Capital Expenditures. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Laboratory's Change To Netincome and Capital Expenditures is 0.54. Overlapping area represents the amount of variation of Change To Netincome that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Change To Netincome and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Netincome of Laboratory of are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Change To Netincome i.e., Laboratory's Change To Netincome and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Change To Netincome

Capital Expenditures

Capital Expenditures are funds used by Laboratory to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Laboratory operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

As of now, Laboratory's Tax Provision is increasing as compared to previous years. The Laboratory's current Enterprise Value is estimated to increase to about 7.8 B, while Selling General Administrative is projected to decrease to under 1.1 B.

	2021	2022	2023	2024 (projected)
Gross Profit	5.6B	4.4B	3.4B	2.0B
Total Revenue	16.1B	14.9B	12.2B	12.8B

Gross Profit Total Revenue

Laboratory fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Inventory	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity
Common Stock Shares Outstanding		0.58	0.48	0.52	0.47	0.41	0.66	0.48	0.5	0.31	0.62	0.09	0.31	0.48	0.7	0.1	0.11	0.66	0.41	0.71	0.64	0.26	0.32	0.19	0.94	0.9
Total Assets	0.58		0.52	0.69	0.98	0.95	0.93	0.95	0.92	0.54	0.99	0.43	0.54	0.95	0.82	0.55	0.39	0.98	0.94	0.84	0.9	0.06	0.85	0.76	0.57	0.32
Other Current Liab	0.48	0.52		0.72	0.54	0.44	0.43	0.58	0.45	0.15	0.52	0.38	0.15	0.42	0.45	0.62	-0.09	0.47	0.46	0.62	0.54	0.38	0.39	0.37	0.43	0.21
Total Current Liabilities	0.52	0.69	0.72		0.72	0.74	0.59	0.74	0.73	0.26	0.68	0.54	0.26	0.69	0.37	0.45	0.03	0.63	0.67	0.6	0.53	0.74	0.75	0.7	0.53	0.35
Total Stockholder Equity	0.47	0.98	0.54	0.72		0.96	0.84	0.98	0.92	0.56	0.95	0.53	0.56	0.96	0.72	0.62	0.28	0.92	0.97	0.76	0.83	0.09	0.91	0.84	0.48	0.19
Property Plant And Equipment Net	0.41	0.95	0.44	0.74	0.96		0.85	0.94	0.95	0.47	0.93	0.54	0.47	0.92	0.63	0.6	0.3	0.9	0.94	0.69	0.75	0.19	0.94	0.9	0.46	0.2
Net Debt	0.66	0.93	0.43	0.59	0.84	0.85		0.78	0.89	0.3	0.96	0.22	0.3	0.79	0.86	0.45	0.55	0.97	0.75	0.87	0.92	0.04	0.68	0.6	0.61	0.48
Retained Earnings	0.48	0.95	0.58	0.74	0.98	0.94	0.78		0.89	0.57	0.92	0.61	0.57	0.94	0.67	0.64	0.11	0.87	0.96	0.72	0.77	0.12	0.91	0.84	0.54	0.2
Accounts Payable	0.5	0.92	0.45	0.73	0.92	0.95	0.89	0.89		0.28	0.92	0.43	0.28	0.83	0.64	0.64	0.33	0.89	0.85	0.7	0.77	0.2	0.91	0.86	0.55	0.37
Cash	0.31	0.54	0.15	0.26	0.56	0.47	0.3	0.57	0.28		0.47	0.36	1.0	0.71	0.52	0.04	0.04	0.5	0.7	0.47	0.45	-0.14	0.46	0.34	0.35	0.05
Non Current Assets Total	0.62	0.99	0.52	0.68	0.95	0.93	0.96	0.92	0.92	0.47		0.39	0.47	0.91	0.85	0.53	0.43	0.99	0.9	0.87	0.92	0.06	0.81	0.72	0.59	0.37
Non Currrent Assets Other	0.09	0.43	0.38	0.54	0.53	0.54	0.22	0.61	0.43	0.36	0.39		0.36	0.52	0.23	0.37	-0.36	0.32	0.52	0.32	0.3	0.28	0.59	0.59	0.22	-0.17
Cash And Short Term Investments	0.31	0.54	0.15	0.26	0.56	0.47	0.3	0.57	0.28	1.0	0.47	0.36		0.71	0.52	0.04	0.04	0.5	0.71	0.47	0.45	-0.13	0.46	0.34	0.35	0.05
Net Receivables	0.48	0.95	0.42	0.69	0.96	0.92	0.79	0.94	0.83	0.71	0.91	0.52	0.71		0.71	0.39	0.29	0.9	0.97	0.74	0.79	0.1	0.86	0.75	0.49	0.2
Non Current Liabilities Total	0.7	0.82	0.45	0.37	0.72	0.63	0.86	0.67	0.64	0.52	0.85	0.23	0.52	0.71		0.31	0.46	0.88	0.67	0.95	0.96	-0.21	0.44	0.32	0.64	0.43
Other Current Assets	0.1	0.55	0.62	0.45	0.62	0.6	0.45	0.64	0.64	0.04	0.53	0.37	0.04	0.39	0.31		-0.02	0.46	0.57	0.36	0.43	0.03	0.65	0.68	0.2	-0.03
Other Stockholder Equity	0.11	0.39	-0.09	0.03	0.28	0.3	0.55	0.11	0.33	0.04	0.43	-0.36	0.04	0.29	0.46	-0.02		0.48	0.23	0.44	0.51	-0.2	0.12	0.1	-0.1	0.07
Total Liab	0.66	0.98	0.47	0.63	0.92	0.9	0.97	0.87	0.89	0.5	0.99	0.32	0.5	0.9	0.88	0.46	0.48		0.87	0.89	0.93	0.03	0.76	0.66	0.63	0.43
Total Current Assets	0.41	0.94	0.46	0.67	0.97	0.94	0.75	0.96	0.85	0.7	0.9	0.52	0.71	0.97	0.67	0.57	0.23	0.87		0.69	0.75	0.07	0.92	0.83	0.46	0.14
Short Long Term Debt Total	0.71	0.84	0.62	0.6	0.76	0.69	0.87	0.72	0.7	0.47	0.87	0.32	0.47	0.74	0.95	0.36	0.44	0.89	0.69		0.96	0.07	0.52	0.4	0.64	0.43
Intangible Assets	0.64	0.9	0.54	0.53	0.83	0.75	0.92	0.77	0.77	0.45	0.92	0.3	0.45	0.79	0.96	0.43	0.51	0.93	0.75	0.96		-0.08	0.58	0.47	0.57	0.36
Short Term Debt	0.26	0.06	0.38	0.74	0.09	0.19	0.04	0.12	0.2	-0.14	0.06	0.28	-0.13	0.1	-0.21	0.03	-0.2	0.03	0.07	0.07	-0.08		0.28	0.28	0.27	0.31
Inventory	0.32	0.85	0.39	0.75	0.91	0.94	0.68	0.91	0.91	0.46	0.81	0.59	0.46	0.86	0.44	0.65	0.12	0.76	0.92	0.52	0.58	0.28		0.95	0.42	0.16
Property Plant And Equipment Gross	0.19	0.76	0.37	0.7	0.84	0.9	0.6	0.84	0.86	0.34	0.72	0.59	0.34	0.75	0.32	0.68	0.1	0.66	0.83	0.4	0.47	0.28	0.95		0.3	0.06
Common Stock	0.94	0.57	0.43	0.53	0.48	0.46	0.61	0.54	0.55	0.35	0.59	0.22	0.35	0.49	0.64	0.2	-0.1	0.63	0.46	0.64	0.57	0.27	0.42	0.3		0.87
Common Stock Total Equity	0.9	0.32	0.21	0.35	0.19	0.2	0.48	0.2	0.37	0.05	0.37	-0.17	0.05	0.2	0.43	-0.03	0.07	0.43	0.14	0.43	0.36	0.31	0.16	0.06	0.87

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	98.6M	98M	97.5M	91.6M	87.6M	96.0M
Total Assets	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Other Current Liab	942.4M	784.2M	967M	1.6B	504.3M	478.7M
Total Current Liabilities	1.9B	2.6B	3.1B	2.8B	3.2B	3.4B
Total Stockholder Equity	7.6B	9.4B	10.3B	10.1B	7.9B	8.3B
Property Plant And Equipment Net	2.6B	2.7B	2.8B	3.0B	2.9B	3.1B
Net Debt	6.7B	5.4B	4.9B	5.9B	5.4B	5.7B
Retained Earnings	7.9B	9.4B	10.5B	10.6B	7.9B	8.3B
Accounts Payable	632.3M	638.9M	621.3M	852.2M	827.5M	868.9M
Cash	337.5M	1.3B	1.5B	430M	536.8M	290.8M
Non Current Assets Total	15.0B	14.9B	15.1B	15.5B	13.0B	13.6B
Non Currrent Assets Other	435.4M	410M	462.6M	432.7M	536.5M	270.8M
Cash And Short Term Investments	337.5M	1.3B	1.5B	430M	536.8M	299.7M
Net Receivables	2.0B	3.0B	3.0B	2.0B	2.1B	2.2B
Liabilities And Stockholders Equity	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Non Current Liabilities Total	7.8B	7.6B	7.3B	7.0B	5.6B	3.1B
Other Current Assets	373.7M	364.8M	478.1M	2.4B	655.3M	688.1M
Other Stockholder Equity	26.8M	110.3M	(192M)	(493.2M)	38.4M	36.5M
Total Liab	10.5B	10.7B	10.1B	10.1B	8.8B	9.3B
Total Current Assets	3.0B	5.1B	5.3B	4.6B	3.8B	4.0B
Short Long Term Debt Total	7.1B	6.8B	6.3B	6.3B	6.0B	3.0B
Intangible Assets	4.0B	4.0B	3.7B	3.9B	3.3B	2.0B
Short Term Debt	621.1M	774.1M	396.5M	471.1M	1.3B	1.4B
Inventory	244.7M	423.2M	401.4M	470.6M	474.6M	498.3M
Property Plant And Equipment Gross	2.6B	2.7B	5.2B	5.7B	5.8B	6.1B
Accumulated Other Comprehensive Income	(372.4M)	(161.9M)	(192M)	(493.2M)	(59.3M)	(62.3M)
Other Liab	1.3B	1.4B	1.2B	1.1B	1.2B	702.7M
Other Assets	356.5M	350.9M	484.2M	440.3M	506.3M	531.7M
Long Term Debt	5.8B	5.4B	5.4B	5.0B	4.1B	3.1B
Property Plant Equipment	2.7B	2.8B	2.8B	3.0B	3.4B	3.6B
Good Will	7.9B	7.8B	8.0B	8.1B	6.1B	4.4B
Current Deferred Revenue	451M	506.5M	558.5M	582.1M	421.7M	442.8M
Net Tangible Assets	(4.3B)	(2.4B)	(1.4B)	(2.0B)	(1.8B)	(1.9B)
Long Term Debt Total	5.9B	5.5B	5.5B	5.1B	5.9B	4.8B

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

2.88

Earnings Share

5.28

Revenue Per Share

151.028

Quarterly Revenue Growth

0.074

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Change To Netincome vs Capital Expenditures Analysis

Change To Netincome vs Capital Expenditures

Change To Netincome vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Change To Netincome

Capital Expenditures

Laboratory fundamental ratios Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Non Current Assets Total
Total Stockholder Equity	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Total Stockholder Equity

Other Stockholder Equity	- 0.36	Non Currrent Assets Other
Short Term Debt	- 0.21	Non Current Liabilities Total
Short Term Debt	- 0.2	Other Stockholder Equity
Common Stock Total Equity	- 0.17	Non Currrent Assets Other
Short Term Debt	- 0.14	Cash
Short Term Debt	- 0.13	Cash And Short Term Investments